Nra Pharmer Industries Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 40075.25%
About Nra Pharmer Industries
Nra Pharmer Industries Private Limited (NPIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 06 November 2020 (Four years and three months 8 days old ). Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvindkumar Singh, Niraj Singh, and Sureshkumar Kewlani serve as directors at the Company.
Company Details
-
Location
Valsad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24290GJ2020PTC118018
-
Company No.
118018
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Nra Pharmer Industries?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvindkumar Singh
|
Whole-Time Director | 06-Nov-2020 | Current |
|
Niraj Singh
|
Whole-Time Director | 06-Nov-2020 | Current |
|
Sureshkumar Kewlani
|
Whole-Time Director | 06-Nov-2020 | Current |
Financial Performance of Nra Pharmer Industries.
Nra Pharmer Industries Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nra Pharmer Industries?
In 2022, Nra Pharmer Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Acna Dye Chem P.Ltd.Arvindkumar Singh is a mutual person
-
Accue Life Science Industries Private Limited
Arvindkumar Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nra Pharmer Industries?
Nra Pharmer Industries has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nra Pharmer Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nra Pharmer Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.